Brain-Health app and coaching trial aims to prevent dementia in At-Risk seniors

NCT ID NCT07376135

Not yet recruiting Prevention Sponsor: Medical University of Vienna Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests whether a personalized lifestyle program combining workshops, remote coaching, and a smartphone app can help adults aged 55-75 at risk for dementia adopt healthier habits. 300 participants will either receive tailored guidance or standard advice. The main goal is to see if the program is practical and engaging, not yet to prove it prevents cognitive decline.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: hybrid multidomain lifestyle intervention (personalized coaching, workshops, app, smartwatch)
What this could lead to: If successful, this could point toward an effective, scalable way to reduce dementia risk in older adults through lifestyle changes.
What could go wrong: This is a small pilot trial focused on feasibility, not proof of effectiveness. The results may not generalize, and long-term adherence to lifestyle changes is challenging.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MILD COGNITIVE IMPAIRMENT (MCI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease Cognition Disorders Cognitive Dysfunction Motor Activity Risk Reduction Behavior subjective cognitive decline dementia prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MILD COGNITIVE IMPAIRMENT (MCI) SUBJECTIVE COGNITIVE DECLINE (SCD)

Contacts and locations

Locations

Medical University of Innsbruck

Graz, Styria, 8010, Austria
Medical University of Innsbruck

Innsbruck, Tyrol, 6020, Austria
Medical University of Vienna

Vienna, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.